An article came out from biotech transfer about my old company forming a new company. I remember all the good time I spend there. All the business discussion about moving the drug forward. Good time, good time!

Non-Profit Roskamp Institute Spins Out Archer Pharma to Market Alzheimer’s Rxs
[October 22, 2008]
By Ben Butkus

yes, I agree it is a bad time to be start a start-up, but the works we did are solid. If the drug is able to reach market, it is going to help a lot of people.